Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • GNRH Receptor
    (2)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Cancer
    (2)
  • Endocrine system
    (2)
Filter
Search Result
Results for "

abarelix

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Abarelix
    R3827, PPI 149
    T10217L183552-38-7
    Abarelix (PPI 149) is a potent gonadotrophin-releasing hormone (GnRH) antagonist, which is used for prostate cancer treatment.
    • $35
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Abarelix acetate
    T68701785804-17-3
    Abarelix acetate is a synthetic third generation gonadotropin-releasing hormone receptor (GnRHR) antagonist. It increases histamine release from rat peritoneal mast cells in vitro and from a human skin model ex vivo. In vivo, abarelix decreases plasma luteinizing hormone (LH) levels six hours post-treatment in castrated rats, with levels returning to baseline within 24 hours.3 Abarelix (2 mg/kg) also transiently decreases plasma testosterone levels in intact rats, with levels returning to baseline within seven days post-treatment. Formulations containing abarelix have previously been used in the treatment of advanced prostate cancer.
    • $3,020
    10-14 weeks
    Size
    QTY
  • Abarelix Acetate (183552-38-7 free base)
    PPI 149 Acetate, Abarelix Acetate
    T10217
    Abarelix (PPI 149; R 3827) Acetate is a potent gonadotrophin-releasing hormone (GnRH) antagonist, used for prostate cancer research.
    • $135
    Inquiry
    Size
    QTY